By Hyonhee Shin
SEOUL (Reuters) – The second of three South Korean expert panels recommended approval on Monday for Moderna’s coronavirus vaccine, based on its safety and efficacy in Phase 3 trials in the United States, the drug safety ministry said.
After the pharmaceutical panel’s backing, the next step is review by a third panel, before the ministry makes a final approval decision.
(Reporting by Hyonhee Shin; Editing by Clarence Fernandez)
